Supplementary Table 1A from MYC-Driven Tumorigenesis Is Inhibited by WRN Syndrome Gene Deficiency
Russell Moser(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Carla Grandori(Precision for Medicine (United States)), Kristin Robinson(Fred Hutch Cancer Center), Masafumi Toyoshima(Nippon Medical School Hospital), Heather L. Howie(Bloodworks Northwest), Kay E. Gurley(Fred Hutch Cancer Center), Jerry Davison(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Christopher J. Kemp(Fred Hutch Cancer Center), Martin Morgan(Roswell Park Comprehensive Cancer Center)
Cited by 0
Related Papers
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
|Annual Review of Cell and Developmental Biology|2000|1.3k
Personalized <i>In Vitro</i> and <i>In Vivo</i> Cancer Models to Guide Precision Medicine
|Cancer Discovery|2017|964
Direct activation of TERT transcription by c-MYC
|Nature Genetics|1999|903
Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion
|Proceedings of the National Academy of Sciences|2000|827
c-Myc binds to human ribosomal DNA and stimulates transcription of rRNA genes by RNA polymerase I
|Nature Cell Biology|2005|671